Equities

Synairgen PLC

SNG:LSE

Synairgen PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)4.74
  • Today's Change0.063 / 1.35%
  • Shares traded216.05k
  • 1 Year change-45.54%
  • Beta-6.5100
Data delayed at least 20 minutes, as of Jul 02 2024 15:26 BST.
More ▼

Financials data is unavailable for this security.

Cash flow Back to Overview

In millions of GBP
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
OPERATIONS
Net income(9.66)(20)(58)
Depreciation/depletion0.070.090.19
Non-Cash items0.160.710.50
Cash taxes paid, supplemental(2.42)(9.09)(3.91)
Cash interest paid, supplemental--00.00
Changes in working capital1.204.9916
Total cash from operations(8.22)(14)(41)
INVESTING
Capital expenditures(0.08)(0.01)(0.03)
Other investing and cash flow items, total2.89(3.61)0.01
Total cash from investing2.81(3.62)(0.02)
FINANCING
Financing cash flow items--00.00
Total cash dividends paid------
Issuance (retirement) of stock, net00.000.01
Issuance (retirement) of debt, net--0(0.12)
Total cash from financing00.00(0.11)
NET CHANGE IN CASH
Foreign exchange effects------
Net change in cash(5.41)(18)(41)
Net cash-begin balance/reserved for future use163475
Net cash-end balance/reserved for future use111634
SUPPLEMENTAL INCOME
Depreciation, supplemental0.070.090.19
Cash interest paid, supplemental--00.00
Cash taxes paid, supplemental(2.42)(9.09)(3.91)
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.